Now available BORUZU®

BORUZU® (bortezomib) is a 505B2 product for the reference product VELCADE®. BORUZU (bortezomib) Injection is a proteasome inhibitor indicated for:

• treatment of adult patients with multiple myeloma
• treatment of adult patients with mantle cell lymphoma

Please see full prescribing information here.